Search
Search Results
##search.searchResults.foundPlural##
-
HIGH SERUM ERYTHROPOIETIN AND FERRITIN LEVELS ASSOCIATED WITH ANEMIA RESPONSE IN MALIGNANT LYMPHOMA
1650PDF: 830HTML: 2871cover letter: 226 -
ANTITHROMBOTIC PROPHYLAXIS IN THE MIDDLE EAST
2054PDF: 907HTML: 1397 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1617PDF: 1156HTML: 265 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3423PDF: 996HTML: 2994 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1672PDF: 1113HTML: 484 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3893PDF: 1546HTML: 349 -
The INFLUENCE OF NUTRITION ON DISEASE SEVERITY AND HEALTH-RELATED QUALITY OF LIFE IN ADULTS WITH SICKLE CELL DISEASE A Prospective Longitudinal Study
2537PDF: 997HTML: 372 -
Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated Acute Myeloid leukemia- A case report and review of literature
2101PDF: 980HTML: 1777Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated AML- IMAGES: 191 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4604PDF: 1527HTML: 8541 -
Leukocyte derived chemotaxin 2 (ALECT2) amyloidosis
1673PDF: 817HTML: 1335 -
-
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1916PDF: 841HTML: 233 -
DETECTION OF ANTINUCLEAR ANTIBODIES TARGETING INTRACELLULAR SIGNAL TRANSDUCTION, METABOLISM, APOPTOTIC PROCESSES AND CELL DEATH IN CRITICAL COVID-19 PATIENTS
1537PDF: 1105HTML: 439Suppl. Figure: 204Suppl. Tables: 225 -
MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman
3526PDF: 1666HTML: 693 -
Respiratory function in pediatric African SCA patients underwent bone marrow transplantation
2205PDF: 812HTML: 1078Spirometry in SCA patients before transplant: 233Spirometry in SCA patients post transplant: 205 -
GLUCOSE HOMEOSTASIS AND ΑSSESSMENT OF Β-CELL FUNCTION BY 3-HOUR ORAL GLUCOSE TOLERANCE (OGTT) IN PATIENTS WITH Β-THALASSEMIA MAJOR WITH SERUM FERRITIN BELOW 1,000 NG/DL: RESULTS FROM A SINGLE ICET-A CENTRE OGTT in thalassemia and iron overload
4061PDF: 1186HTML: 471 -
NASAL NK/T- CELL LYMPHOMA. COMPARATIVE ANALYSIS OF A MEXICAN POPULATION
1846PDF: 1033HTML: 1885Tables: 201 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2705PDF: 1680HTML: 2453Table1: 214 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1809PDF: 1347HTML: 641 -
THE HEMATOLOGICAL PARAMETERS AND BIOCHEMICAL MARKERS OF IRON STATUS IN ALFA-THALASSEMIA 3.7KB DELETION FROM METROPOLITAN REGION OF MANAUS, AMAZONAS, BRAZIL. alfa-Thalassemia 3.7 deletion From Amazonas, Brazil.
4249PDF: 674HTML: 472 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3511PDF: 1339HTML: 2345Fi.1 Gritti.Rambaldi: 238 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
3201PDF: 1668HTML: 368







